SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence is a research paper published in Clinical Kidney Journal (2023). On theSindex it has a DataRank of 0.550. It has been cited 38 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.550
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Amicus
Fresenius Medical Care
GSK
Vifor Pharma
AstraZeneca
Bayer
Idorsia
Astellas Pharma US
Amgen
Chiesi Farmaceutici
Menarini Group
Alexion
Sanofi-Genzyme
Advicciene
Kyowa Kirin
Novo-Nordisk
FWCI
4.01
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals